Different Models of Tracheal Catheters Are Used for Female Thyroid Glands

May 24, 2026 updated by: Anqing Municipal Hospital

A Randomized Controlled Trial Comparing Different Models of Tracheal Tube for Thyroid Surgery in Women

Objective:Compare whether the use of tracheal catheters of models 6.0 and 6.5 causes less sore throat in women after thyroid surgery compared with the traditional use of model 7.0 tracheal catheters.Methods: Investigators enrolled 180 female patients with American Society of Anesthesiologists (ASA) physical status I and III, aged 18-65 years, and scheduled for elective undergoing thyroid surgery with general anesthesia. The participants were randomly assigned into three groups(n=60 each group):Group A: Tracheal catheter group with an inner diameter of 6.0mm, Group B: Tracheal catheter group with an inner diameter of 6.5mm, Group C: Tracheal catheter group with an inner diameter of 7.0mm.The incidence and severity of postoperative sore throat were recorded in three groups at 1 h, 6 h, 24 h and 48 h after operation.

Study Overview

Study Type

Observational

Enrollment (Estimated)

180

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Sun Ling Lu Sun Ling LU, Master's degree
  • Phone Number: 15955565806
  • Email: 348092640@qq.com

Study Contact Backup

  • Name: Xu Si Qi Xu Si Qi, Doctor
  • Phone Number: 13865192106
  • Email: errtg555@163.com

Study Locations

    • Anhui
      • Anqing, Anhui, China, 246003
        • Recruiting
        • Department of Anqing Hospital Anesthesiology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Healthy female thyroid surgery patients, ages 18-65 years, did not have serious systemic disease

Description

Inclusion Criteria:

  • Female;
  • Thyroid surgery should be performed under general anesthesia (GA) at an appropriate time;
  • ASA grade I-III;
  • Aged 18-65 years;
  • BMI less than 35Kg/m2
  • In line with ethics, patients voluntarily accept this experiment and sign informed consent.

Exclusion Criteria:

  • Reflux esophagitis, preoperative sore throat, chronic pharyngitis, preoperative hoarseness, use of anticoagulants or corticosteroids, high risk of reflux or aspiration, dysphagia, previous oral or pharyngeal surgical intervention, bleeding disorder, severe heart, lung, liver and kidney dysfunction
  • Upper respiratory tract infection occurred within 2 weeks before surgery
  • Unable to insert ET (no more than two intubations)
  • Patients with hoarseness or sore throat before surgery
  • Language communication, hearing impairment or brain dysfunction such as stroke, unable to communicate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
6.0#
Insert the tracheal tube of model 6.0#
6.5#
Insert the tracheal tube of model 6.5#
7.0#
Insert the tracheal tube of model 7.0#

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The incidence of postoperative sore throat
Time Frame: at 1 hour, 6 hour, 24 hour and 48 hour after operation
The incidence of postoperative sore throat
at 1 hour, 6 hour, 24 hour and 48 hour after operation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 25, 2025

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

October 1, 2026

Study Registration Dates

First Submitted

April 19, 2025

First Submitted That Met QC Criteria

May 5, 2025

First Posted (Actual)

May 13, 2025

Study Record Updates

Last Update Posted (Actual)

May 27, 2026

Last Update Submitted That Met QC Criteria

May 24, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sore Throat

Subscribe